High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: Is it feasible?

Author:

De Pas T.,De Braud F.,Orlando L.,Nolè F.,Munzone E.,Zampino M.G.,Fazio N.,Aapro M.S.,Goldhirsch A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference12 articles.

1. Increasing continuous infusion ifosfamide and bolus epirubicin in soft tissue sarcoma patients;Buonadonna;Proc Am Soc Clin Oncol,1996

2. Dose intensive chemotherapy with or without stem cell support for adult patients with advanced soft tissue sarcoma: Final results of a phase II study and preliminar results of a phase I—II study;Reichardt;Proc Am Soc Clin Oncol,1997

3. Dose intensive therapy does improve response rates – update results of studies of adriamycin and ifosfamide with growth factors in patients with untreated soft tissue sarcomas;Patel;Proc Am Soc Clin Oncol,1997

4. A phase I–II study of sequential, dose escalated, high-dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas;Bokemeyer;Cancer,1997

5. Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte macrophage colony stimulating factor in advanced soft tissue sarcomas: A pilot study;Frustaci;J Clin Oncol,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3